Smith & Nephew (SNN) Gains from Sales and Divestitures (2012)
Smith & Nephew (SNN) posted quarterly Gains from Sales and Divestitures of -$251.0 million for Q1 2012.
Smith & Nephew (SNN) Gains from Sales and Divestitures (2012) Analysis & Trends
Smith & Nephew (SNN) has reported Gains from Sales and Divestitures for 1 consecutive years, with -$251.0 million the latest figure, recorded in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Steris | 21.49 Bn | 21.05 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | -251.00 Mn |
| Mar 31, 2012 | -251.00 Mn |